The Bio/Pharma Beat

    View Authors July 2019

    We would like to share with you the inaugural issue of the Bio/Pharma Beat, our monthly newsletter reporting on the patent law developments you should know in biotech, biologics and pharmaceutical cases, legislation and federal agency actions. This month’s issue covers relevant news from June 2019, including:

    • Rare appearances by the doctrine of equivalents (formulation patent) and prior public use (polymorph patent) – in the same Federal Circuit decision
    • The FDA is “enhancing” its Paragraph IV Certifications List
    • A method for deriving a composition from a particular natural source is patent eligible